Skip to main content
Erschienen in: Heart and Vessels 3/2015

01.05.2015 | Original Article

A prognostic index for risk stratification for acute heart failure and death in subjects with ischemic cardiomyopathy and cardiac defibrillator

verfasst von: Lanfranco Antonini, Cristina Mollica, Antonio Auriti, Christian Pristipino, Vincenzo Pasceri, Francesca Leone, Salvatore Greco

Erschienen in: Heart and Vessels | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

To propose a clinical prognostic index for death and heart failure in patients with ischemic cardiomyopathy implanted with an ICD. This prospective study included 192 consecutive patients (age 68 ± 10) recruited from 2004 to 2009 and implanted with an ICD for MADIT II criteria. All patients performed 24-h ambulatory blood pressure monitoring after discharge and common haematological samples. The prognostic index (PI) was built according to the formula: 120 − age + mean 24 h systolic blood pressure − (creatinine × 10). Other variables were assessed: EF, haemoglobin concentration, mean 24 h heart rate and diastolic blood pressure, sodium level, pacing mode and diabetes. Non-arrhythmic cardiac death and new hospitalizations for heart failure during 1-year follow-up were the combined end point. A total of 48 events (25 %) occurred during the follow-up: 7 cardiac deaths and 41 hospitalizations for acute heart failure. Cox proportional-hazards model showed that PI was the only predictor of events (HR = 0.96; CI 95 % 0.944–0.976, p < 0.0001). ROC curve showed that PI best cut-off was 144, with AUC 0.79, p < 0.0001; sensitivity 77 %, specificity 74 %, positive predictive value 50 %, negative predictive value 90 %. PI was predictive of events in a clinical setting where EF had no predictive value. PI works according to the rule “the lower the worse”. The high negative predictive value (90 %) of PI allows to identify subjects at lower risk for death and heart failure. PI can be a practical tool to stratify risk in ischemic cardiomyopathy.
Literatur
1.
Zurück zum Zitat Cevik C, Perez-Verdia A, Nugent K (2009) Implantable cardioverter defibrillators and their role in heart failure progression. Europace 11:710–715CrossRefPubMed Cevik C, Perez-Verdia A, Nugent K (2009) Implantable cardioverter defibrillators and their role in heart failure progression. Europace 11:710–715CrossRefPubMed
2.
Zurück zum Zitat Antonini L, Colivicchi F, Pasceri V, Greco S, Varveri A, Turani L, Kol A, Santini M (2008) A prognostic index relating 24-hour ambulatory blood pressure to cardiac events in ischemic cardiomyopathy following defibrillator implantation. Pacing Clin Electrophysiol 31:1089–1094CrossRefPubMed Antonini L, Colivicchi F, Pasceri V, Greco S, Varveri A, Turani L, Kol A, Santini M (2008) A prognostic index relating 24-hour ambulatory blood pressure to cardiac events in ischemic cardiomyopathy following defibrillator implantation. Pacing Clin Electrophysiol 31:1089–1094CrossRefPubMed
3.
Zurück zum Zitat Antonini L, Pasceri V, Mollica C, Ficili S, Poti G, Aquilani S, Santini M, La Rocca S (2011) Ambulatory blood pressure monitoring, 2D-echo and clinical variables to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation. J Cardiovac Med 12:334–339CrossRef Antonini L, Pasceri V, Mollica C, Ficili S, Poti G, Aquilani S, Santini M, La Rocca S (2011) Ambulatory blood pressure monitoring, 2D-echo and clinical variables to cardiac events in ischaemic cardiomyopathy following cardioverter-defibrillator implantation. J Cardiovac Med 12:334–339CrossRef
4.
Zurück zum Zitat MADIT Executive Committee Multicenter Automatic Defibrillator (1991) Implantation trial (MADIT):design and clinical protocol. Pacing Clin Electrophysiol 14:920–927CrossRef MADIT Executive Committee Multicenter Automatic Defibrillator (1991) Implantation trial (MADIT):design and clinical protocol. Pacing Clin Electrophysiol 14:920–927CrossRef
5.
Zurück zum Zitat Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML (2002) Multicenter automatic defibrillator implantation trial investigators: prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883CrossRefPubMed Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML (2002) Multicenter automatic defibrillator implantation trial investigators: prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346:877–883CrossRefPubMed
6.
Zurück zum Zitat White WB, Lund-Johansen P, Omvik P (1990) Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise. Am J Cardiol 65:60–65CrossRefPubMed White WB, Lund-Johansen P, Omvik P (1990) Assessment of four ambulatory blood pressure monitors and measurements by clinicians versus intraarterial blood pressure at rest and during exercise. Am J Cardiol 65:60–65CrossRefPubMed
7.
Zurück zum Zitat Otterstad JE, Froeland G, Sutton M, Holme J (1997) Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimension and function. Eur Heart J 18:507–513CrossRefPubMed Otterstad JE, Froeland G, Sutton M, Holme J (1997) Accuracy and reproducibility of biplane two-dimensional echocardiographic measurements of left ventricular dimension and function. Eur Heart J 18:507–513CrossRefPubMed
8.
Zurück zum Zitat Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JM, Warnica JW (2003) Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol 42:1446–1453CrossRefPubMed Lewis EF, Moye LA, Rouleau JL, Sacks FM, Arnold JM, Warnica JW (2003) Predictors of late development of heart failure in stable survivors of myocardial infarction: the CARE study. J Am Coll Cardiol 42:1446–1453CrossRefPubMed
9.
Zurück zum Zitat Colonna P, Antonelli G (2011) In search of the best prognostic factor in patients with congestive heart failure: the paradox of ejection fraction without prognostic significance. J Cardiovasc Med 12:314–317CrossRef Colonna P, Antonelli G (2011) In search of the best prognostic factor in patients with congestive heart failure: the paradox of ejection fraction without prognostic significance. J Cardiovasc Med 12:314–317CrossRef
10.
Zurück zum Zitat Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM (1995) Predictors of 30 day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41021 patients GUSTO I investigators. Circulation 91:1659–1668CrossRefPubMed Lee KL, Woodlief LH, Topol EJ, Weaver WD, Betriu A, Col J, Simoons M, Aylward P, Van de Werf F, Califf RM (1995) Predictors of 30 day mortality in the era of reperfusion for acute myocardial infarction. Results from an international trial of 41021 patients GUSTO I investigators. Circulation 91:1659–1668CrossRefPubMed
11.
Zurück zum Zitat Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML (2007) MADIT II Investigators. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 49:1427–1433CrossRefPubMed Goldenberg I, Moss AJ, McNitt S, Zareba W, Hall WJ, Andrews ML (2007) MADIT II Investigators. Inverse relationship of blood pressure levels to sudden cardiac mortality and benefit of the implantable cardioverter-defibrillator in patients with ischemic left ventricular dysfunction. J Am Coll Cardiol 49:1427–1433CrossRefPubMed
12.
Zurück zum Zitat Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, Manisty CH, Mayet J, Francis DP (2009) Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 95(1):56–62CrossRefPubMed Raphael CE, Whinnett ZI, Davies JE, Fontana M, Ferenczi EA, Manisty CH, Mayet J, Francis DP (2009) Quantifying the paradoxical effect of higher systolic blood pressure on mortality in chronic heart failure. Heart 95(1):56–62CrossRefPubMed
13.
Zurück zum Zitat Cheng RK, Horwich TB, Fonarow GC (2008) Relation of systolic blood pressure to survival in both ischemic and non ischemic systolic heart failure. Am J Cardiol 102:1698–1705CrossRefPubMedCentralPubMed Cheng RK, Horwich TB, Fonarow GC (2008) Relation of systolic blood pressure to survival in both ischemic and non ischemic systolic heart failure. Am J Cardiol 102:1698–1705CrossRefPubMedCentralPubMed
14.
Zurück zum Zitat Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539CrossRefPubMed Ronco C, Haapio M, House AA, Anavekar N, Bellomo R (2008) Cardiorenal syndrome. J Am Coll Cardiol 52:1527–1539CrossRefPubMed
15.
Zurück zum Zitat Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ (2001) Reduced kidney function and anemia as risk factor for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38:955–962CrossRefPubMed Al-Ahmad A, Rand WM, Manjunath G, Konstam MA, Salem DN, Levey AS, Sarnak MJ (2001) Reduced kidney function and anemia as risk factor for mortality in patients with left ventricular dysfunction. J Am Coll Cardiol 38:955–962CrossRefPubMed
16.
Zurück zum Zitat ONTARGET investigators (2009) Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens 27:1360–1369CrossRef ONTARGET investigators (2009) Prognostic value of blood pressure in patients with high vascular risk in the Ongoing Telmisartan Alone and in combination with Ramipril Global Endpoint Trial study. J Hypertens 27:1360–1369CrossRef
17.
Zurück zum Zitat Storrow AB, Emerman CL, Abraham WT, Wagoner LE, Collins S, Lindsell C, Wynne J (2004) Clinical risk factors for adverse outcomes in emergency department patients with acute decompensated heart failure: an ADHERE registry analysis. Ann Emerg Med 44(4):S72CrossRef Storrow AB, Emerman CL, Abraham WT, Wagoner LE, Collins S, Lindsell C, Wynne J (2004) Clinical risk factors for adverse outcomes in emergency department patients with acute decompensated heart failure: an ADHERE registry analysis. Ann Emerg Med 44(4):S72CrossRef
18.
Zurück zum Zitat Fonarow GC, Adams KF, Abrahan WT (2005) Risk stratification for in hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293(5):572–580CrossRefPubMed Fonarow GC, Adams KF, Abrahan WT (2005) Risk stratification for in hospital mortality in acutely decompensated heart failure: classification and regression tree analysis. JAMA 293(5):572–580CrossRefPubMed
19.
Zurück zum Zitat Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113:1424–1433CrossRefPubMed Levy WC, Mozaffarian D, Linker DT, Sutradhar SC, Anker SD, Cropp AB (2006) The Seattle Heart Failure Model: prediction of survival in heart failure. Circulation 113:1424–1433CrossRefPubMed
20.
Zurück zum Zitat Kallistratos, Poulimenos L, Pavlidis AN, Dritsas A, Laoutaris ID, Manolis AJ, Cokkinos DV (2012) Prognostic significance of blood pressure response to exercise in patients with systolic heart failure. Heart Vessels 27(1):46–52CrossRefPubMed Kallistratos, Poulimenos L, Pavlidis AN, Dritsas A, Laoutaris ID, Manolis AJ, Cokkinos DV (2012) Prognostic significance of blood pressure response to exercise in patients with systolic heart failure. Heart Vessels 27(1):46–52CrossRefPubMed
21.
Zurück zum Zitat Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW (2000) The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35:681–689CrossRefPubMed Dries DL, Exner DV, Domanski MJ, Greenberg B, Stevenson LW (2000) The prognostic implications of renal insufficiency in asymptomatic and symptomatic patients with left ventricular systolic dysfunction. J Am Coll Cardiol 35:681–689CrossRefPubMed
22.
Zurück zum Zitat Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, Krumholz HM (2003) Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9(1):13–25CrossRefPubMed Smith GL, Vaccarino V, Kosiborod M, Lichtman JH, Cheng S, Watnick SG, Krumholz HM (2003) Worsening renal function: what is a clinically meaningful change in creatinine during hospitalization with heart failure? J Card Fail 9(1):13–25CrossRefPubMed
23.
Zurück zum Zitat Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S (2004) A multivariate model predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 116(5):300–304CrossRefPubMed Brophy JM, Dagenais GR, McSherry F, Williford W, Yusuf S (2004) A multivariate model predicting mortality in patients with heart failure and systolic dysfunction. Am J Med 116(5):300–304CrossRefPubMed
24.
Zurück zum Zitat Forman DE, Butler J, Wang Y (2004) Incidence, predictors at admission and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67CrossRefPubMed Forman DE, Butler J, Wang Y (2004) Incidence, predictors at admission and impact of worsening renal function among patients hospitalized with heart failure. J Am Coll Cardiol 43:61–67CrossRefPubMed
25.
Zurück zum Zitat Kimura M, Hiramitsu S, Miyagishima K, Mori K, Yoda R, Kato S, Kato Y, Morimoto S, Hishida H, Ozaki Y (2010) Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure. Heart Vessels 25(4):306–312CrossRefPubMed Kimura M, Hiramitsu S, Miyagishima K, Mori K, Yoda R, Kato S, Kato Y, Morimoto S, Hishida H, Ozaki Y (2010) Cardio-renal interaction: impact of renal function and anemia on the outcome of chronic heart failure. Heart Vessels 25(4):306–312CrossRefPubMed
26.
Zurück zum Zitat Sze E, Moss AJ, McNitt S, Barsheshet A, Andrews ML, Zareba W, Goldenberg I (2010) For the Multicenter Automatic Defibrillator Implantation Trial II Investigator. J Cardiovas Electrophysiol 21:1217–1223CrossRef Sze E, Moss AJ, McNitt S, Barsheshet A, Andrews ML, Zareba W, Goldenberg I (2010) For the Multicenter Automatic Defibrillator Implantation Trial II Investigator. J Cardiovas Electrophysiol 21:1217–1223CrossRef
27.
Zurück zum Zitat Blackledge HM, Tomlinson J, Squire IB (2003) Prognosis for patients newly admitted to hospital with heart failure; survival trends in 12220 index admissions in Leicestershire 1993–2001. Heart 89:615–620CrossRefPubMedCentralPubMed Blackledge HM, Tomlinson J, Squire IB (2003) Prognosis for patients newly admitted to hospital with heart failure; survival trends in 12220 index admissions in Leicestershire 1993–2001. Heart 89:615–620CrossRefPubMedCentralPubMed
28.
Zurück zum Zitat Rich MW, Bec Kham V, Wittenberg C, Leven CL, Freedland KE, Carney RM (1995) A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333:1190–1195CrossRefPubMed Rich MW, Bec Kham V, Wittenberg C, Leven CL, Freedland KE, Carney RM (1995) A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med 333:1190–1195CrossRefPubMed
Metadaten
Titel
A prognostic index for risk stratification for acute heart failure and death in subjects with ischemic cardiomyopathy and cardiac defibrillator
verfasst von
Lanfranco Antonini
Cristina Mollica
Antonio Auriti
Christian Pristipino
Vincenzo Pasceri
Francesca Leone
Salvatore Greco
Publikationsdatum
01.05.2015
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 3/2015
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-014-0494-7

Weitere Artikel der Ausgabe 3/2015

Heart and Vessels 3/2015 Zur Ausgabe

Editorial

Editorial

„Jeder Fall von plötzlichem Tod muss obduziert werden!“

17.05.2024 Plötzlicher Herztod Nachrichten

Ein signifikanter Anteil der Fälle von plötzlichem Herztod ist genetisch bedingt. Um ihre Verwandten vor diesem Schicksal zu bewahren, sollten jüngere Personen, die plötzlich unerwartet versterben, ausnahmslos einer Autopsie unterzogen werden.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Schlechtere Vorhofflimmern-Prognose bei kleinem linken Ventrikel

17.05.2024 Vorhofflimmern Nachrichten

Nicht nur ein vergrößerter, sondern auch ein kleiner linker Ventrikel ist bei Vorhofflimmern mit einer erhöhten Komplikationsrate assoziiert. Der Zusammenhang besteht nach Daten aus China unabhängig von anderen Risikofaktoren.

Semaglutid bei Herzinsuffizienz: Wie erklärt sich die Wirksamkeit?

17.05.2024 Herzinsuffizienz Nachrichten

Bei adipösen Patienten mit Herzinsuffizienz des HFpEF-Phänotyps ist Semaglutid von symptomatischem Nutzen. Resultiert dieser Benefit allein aus der Gewichtsreduktion oder auch aus spezifischen Effekten auf die Herzinsuffizienz-Pathogenese? Eine neue Analyse gibt Aufschluss.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.